Ensysce Biosciences (ENSC) Receivables - Other (2021 - 2025)
Ensysce Biosciences' Receivables - Other came in at $420,345 for Q4 2025, up 238.7% from $124,115 a year earlier.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Receivables - Other (2021 - 2025) Analysis & Trends
Going back to Q2 2021, Ensysce Biosciences' Receivables - Other data covers 19 quarters.
- Receivables - Other carries a four-year compound annual growth rate of -1.2% (FY2021 to FY2025).
- Going back by year, Receivables - Other was $124,115 in FY2024 (+27.2%), $97,561 in FY2023 (-64.8%), $276,821 in FY2022 (-37.3%) and $441,721 in FY2021.
- The five-year range for quarterly Receivables - Other is $4,411 (Q3 2025) to $1.78 million (Q3 2024).
- Year-over-year, Receivables - Other increased in four of the last seven quarters, with growth averaging 81.2%.
- The fastest year-over-year change in Receivables - Other over five years came in Q2 2025 (growth of 437.4%), and the weakest in Q3 2025 (a decline of 99.8%).
- Business Quant data shows ENSC's Receivables - Other at $4,411 (Q3 2025), $1.2 million (Q2 2025) and $22,002 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.67 Bn | 1,100.26 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 614.28 Bn | 532.81 Bn | 17.26 Bn |
| 3 | AbbVie | 503.23 Bn | 476.34 Bn | 12.70 Bn |
| 4 | Merck | 368.28 Bn | 322.66 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.22 Bn | 262.21 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.55 Bn | 235.23 Bn | 12.86 Bn |
| 7 | Amgen | 235.92 Bn | 191.31 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.78 Bn | 164.98 Bn | 6.22 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn |
| 10 | Ensysce Biosciences | 1.28 Mn | -9.96 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 420,345.00 |
| Sep 30, 2025 | 4,411.00 |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 22,002.00 |
| Dec 31, 2024 | 124,115.00 |
| Sep 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 224,223.00 |
| Mar 31, 2024 | 96,224.00 |
| Dec 31, 2023 | 97,561.00 |
| Sep 30, 2023 | 107,738.00 |
| Jun 30, 2023 | 107,578.00 |
| Mar 31, 2023 | 289,312.00 |
| Dec 31, 2022 | 276,821.00 |
| Sep 30, 2022 | 140,813.00 |
| Jun 30, 2022 | 276,631.00 |
| Mar 31, 2022 | 808,601.00 |
| Dec 31, 2021 | 441,721.00 |
| Sep 30, 2021 | 86,867.00 |
| Jun 30, 2021 | 75,354.00 |
API Access
Ensysce Biosciences Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();